MiR-21 can inhibit apoptosis and inflammation by targeting KBTBD7, regulate angiogenesis through STRN/NOS3, and promote myocardial fibrosis through the TGF-β/Smad7 signaling pathway. The gene discussed is STRN; the disease is Myocardial fibrosis.